Profil
Tatsuya Yoneyama served as President & Chief Executive Officer at Akros Pharma, Inc. from 2005 to 2005.
Prior to that, he worked as Senior Director-Business Development at SymBio Pharmaceuticals Ltd.
and as Principal at JT Pharmaceuticals.
Yoneyama received his undergraduate degree from Hokkaido University in 1970.
Ehemalige bekannte Positionen von Tatsuya Yoneyama
Unternehmen | Position | Ende |
---|---|---|
Akros Pharma, Inc.
Akros Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akros Pharma, Inc. manufactures pharmaceutical products. It offers disease and conditions related products, pipeline products, and research and development services. The company was founded on January 5, 1999 and is headquartered in Princeton, NJ. | Präsident | 01.01.2005 |
JT Pharmaceuticals
JT Pharmaceuticals Pharmaceuticals: MajorHealth Technology JT Pharmaceuticals manufactures pharmaceutical products. The Japanese company was founded by James R. McNab and he has been the CEO since incorporation. | Corporate Officer/Principal | - |
SYMBIO PHARMACEUTICALS LIMITED | Corporate Officer/Principal | - |
Ausbildung von Tatsuya Yoneyama
Hokkaido University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
SYMBIO PHARMACEUTICALS LIMITED | Health Technology |
Private Unternehmen | 2 |
---|---|
Akros Pharma, Inc.
Akros Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akros Pharma, Inc. manufactures pharmaceutical products. It offers disease and conditions related products, pipeline products, and research and development services. The company was founded on January 5, 1999 and is headquartered in Princeton, NJ. | Health Technology |
JT Pharmaceuticals
JT Pharmaceuticals Pharmaceuticals: MajorHealth Technology JT Pharmaceuticals manufactures pharmaceutical products. The Japanese company was founded by James R. McNab and he has been the CEO since incorporation. | Health Technology |